Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 55.80
+2.70 (5.08%)
May 30, 2025, 3:00 PM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 6.10 billion as of June 2, 2025. Its market cap has decreased by -6.57% in one year.
Market Cap
6.10B
Enterprise Value
6.05B
Revenue
1.06B
Ranking
n/a
PE Ratio
46.60
Stock Price
55.80
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 6.10B, a decrease of -36.53%. That is a compound annual growth rate of -10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 6.10B | 44.41% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |